Rare diseases
Investigational molecules
Locations
Back to Denmark1 426 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
NorwayStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
FranceStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
DenmarkStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
DenmarkStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
DenmarkStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
BelgiumStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
DenmarkStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
DenmarkStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
DenmarkStudy on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients
SwedenStudy on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
DenmarkStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
AustriaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
